Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Magenta Care Continuum Joins the Olive Library to Revolutionize the Risk Adjustment Process
Olive, the automation company creating the Internet of Healthcare, today announced its partnership with Magenta Care […]
Leia Inc. Partners With Anatomage to Enable 3D Stereoscopic Learning Through Anatomage VR
Leia Inc., the leading 3D experience platform leveraging proprietary Nanotechnology and AI to democratize the […]
Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care
Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health […]
Dotmatics Supports Umicore Corporate R&D in Processing of Experimental Data
Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it […]
AstraZeneca Signs Licence Agreement With RQ Biotechnology for Monoclonal Antibodies Against COVID-19
AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a […]
Thabor Therapeutics Appoints Jérémie Mariau as Ceo
Thabor Therapeutics, a company developing an innovative treatment for patients living with chronic mucosal inflammatory […]
Mirati Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of Laurie Stelzer as […]
BenevolentAI Achieves Third Milestone in Its AI-enabled Drug Discovery Collaboration With AstraZeneca
BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug discovery company, today announces that AstraZeneca […]
LifeArc Co-founded Company RQ Bio Signs Licensing Agreement With AstraZeneca Worth Up to $157m Plus Royalties for Monoclonal Antibodies Against SARS-CoV-2
LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has signed […]
Avacta Announces AffyXell Expands Its Strategic Partnership With GenScript ProBio
Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more